Zurich, Switzerland (GenevaLunch) - Switzerland’s second death from A/H1N1 flu has taken place just a week after the first, but doctors point out that the patient, a woman over 50 with diabetes, could well have died if she contracted regular flu. TSR quotes the head of public health in Zurich as saying that in a normal year Zurich alone has some 100 flu-related deaths, generally caused by complications from existing health problems.
EPFL, campus in Lausanne
Lausanne, Switzerland (GenevaLunch) – A group based mainly at EPFL in Lausanne have identified a molecule that may provide a stronger tool in the fight against excess weight and diabetes type 2, both of which are increasing at alarming rates worldwide, according to the journal Cell Metabolism.
Researchers Kristina Schoonjans, Johan Auwerx, Hiroyasu Yamamoto and Chikage Matakiand at EPFL, the Lausanne federal polytechnic university, working with Charles Thomas at EPFL and Roberto Pellicciari at the University of Perugia in Italy, say the selective molecule, called INT-777, can activate the TGR5 protein. TGR5 controls secretion of a hormone that has a critical role in pancreatic function and regulating blood sugar levels.
Title: Junior diabetes cup
Location: Bout-du-monde, Geneva
Link out: Click here
Description: Over 170 junior players (6 to 18 years old), suffering from diabetes type 1 and representing over 10 countries will meet during a weekend of fun and sports in Geneva.
Start Date: 22 Aug 2009
End Date: 23 Aug 2009
